In 2016, UACT received a $5,000 flash grant from the Shuttleworth Foundation, which was used to support a technical meeting in Geneva in January 2017, on the proposal for a Cancer Innovation Fund. (Blog about the event here)


UACT does not accept funding from drug companies.

If you are interested in supporting our work, you can donate to UACT here or contact us at